Cerebras Systems (CBRS) designs wafer-scale AI processors and sells them both as on-premises systems and as cloud inference capacity, and it has traded publicly only since its May 2026 Nasdaq listing. The stock is down 9.19% and last changed hands at $98.73, versus Friday's close of $108.72. The move is unambiguously lower. The immediate cause is a round of price-target reductions issued after the third-quarter report, combined with a reassessment of guidance that had already been priced in during Friday's rally.
The most direct driver was the Street's recalibration of valuation. UBS lowered its target to $155 from $250 while keeping a Buy rating; Needham cut to $200 from $300 and kept a Buy; Mizuho moved to $240 from $300 with an Outperform rating; and Craig-Hallum reduced its target to $250 from $325, also staying positive. Every firm retained a constructive rating, but the direction of the revisions was uniform and substantial. For a name priced at roughly a $24 billion market value after a volatile debut, multi-hundred-dollar target reductions function as a valuation ceiling signal, and sellers acted on it at the first opportunity.
The fundamental update itself was strong: core revenue rose 70% to $230.9 million, fourth-quarter core revenue was guided to $310-$330 million, and full-year 2026 core revenue guidance rose to $940-$960 million from $880-$890 million. The complication is 2027. Management's expectation of tripling revenue implies about $2.85 billion against a consensus near $2.92 billion, leaving no upside surprise for next year. The report also carried a $161.2 million GAAP net loss on a 20% GAAP gross margin, plus disclosure that OpenAI capacity tranches are running behind schedule. That mix supports a re-rating rather than a sustained breakout.
Friday's tape already contained the warning. The stock opened at $108.40, spiked to $120.44, then closed at $108.72 — a wide outside day that left buyers stranded near the highs. The lockup that had restricted early investors expired on Nov. 9, removing a structural constraint on supply just as the stock attempted to rebound off its Nov. 5 low of $77.84. With the shares still roughly 47% below the $185 IPO price, rallies continue to meet holders looking to exit near cost.
Participation was heavy around the event: Friday's volume of about 21 million shares ran roughly four times the 60-day average near 5 million, and the stock has averaged an absolute daily move of about 4.5% over that stretch. Monday's selling pushed the price below Friday's intraday low of $101.18 and back under the 61.8% retracement near $104.24 that had capped prior rebound attempts. The action is best characterized as stock-specific post-earnings repricing rather than a macro-driven liquidation; the pressure is concentrated in the equity's own valuation debate.
The scale runs from 0, meaning no meaningful news and an ordinary move for the stock, to 100, meaning transformative news and a rare, extreme price move. Cerebras Systems scores 29 out of 100. The verified news was moderate: several banks trimmed price targets after the quarterly report, a material but not transformational adjustment for a company of this size. The decline was also unremarkable by this stock's standards — about 2.05 times its typical daily move, with eight of the past 60 sessions producing equal or larger swings. Modest news and a familiar-sized drop combine into a low score.
Attention shifts to fourth-quarter execution, with results expected in February. Delivery against the $310-$330 million core revenue guide, a 47%-49% core gross margin, and an operating margin near breakeven is the near-term test. Three hyperscaler relationships — Microsoft, Oracle, and AWS — should begin contributing revenue from the first quarter of 2027, while roughly 700 megawatts of contracted data center capacity is scheduled for delivery by the end of 2027. Risks include customer concentration around OpenAI, capacity timing slippage, the gap between core and GAAP profitability, and potential cancellation exposure management pegs below 5% of committed megawatts. Analysts remain broadly positive but have made clear that 2027 estimates leave little room for error.
Tickeron's Trending AI Robots page is a curated view of the platform's strongest automated strategies under present market conditions. Tickeron offers hundreds of AI trading bots spanning thousands of tickers, and the bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade. Only the top performers currently earning their place are highlighted in this section. For readers tracking volatile names like this one, it offers a structured way to see which strategies are working right now. Explore the page to compare live performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CBRS declined for three days, in 28 of 28 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CBRS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 5 of 5 cases where CBRS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for CBRS just turned positive on November 09, 2026. Looking at past instances where CBRS's MACD turned positive, the stock continued to rise in 1 of 2 cases over the following month. The odds of a continued upward trend are 50%.
Following a +18.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBRS advanced for three days, in 17 of 22 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CBRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.327) is normal, around the industry mean (5.443). P/E Ratio (-19.264) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (63.694) is also within normal values, averaging (46.468).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CBRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors